← Dashboard
Aug 18, 2026 04:00 PM ET
Catalyst
FDA/Bio
MONOPAR: LICENSING AGREEMENT AND ROLLING NDA SUBMISSION SERVE AS CATALYSTS FOR 'STRONG BUY' - SEEKINGALPHA
Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.
What changed
Why it matters
Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →